Research graph
References from The role of metacognitive beliefs in impulse control disorders and addictive-like behaviors in Parkinson’s disease: an exploratory study. Local targets link to admitted publications; unresolved targets remain external evidence.
Parkinson’s disease and parkinsonism
10.1016/j.amjmed.2019.03.001 · 2019 · External reference
The epidemiology of Parkinson’s disease
10.1016/s0140-6736(23)01419-8 · 2024 · External reference
Impulse control disorders in Parkinson’s disease: definition, epidemiology, risk factors, neurobiology and management
10.1016/s1353-8020(09)70847-8 · 2009 · External reference
Impulse control disorders in Parkinson’s disease: Epidemiology, pathogenesis and therapeutic strategies
10.3389/fpsyt.2021.635494 · 2021 · External reference
Impulse control disorders in patients with Parkinson’s disease receiving dopamine replacement therapy: evidence and implications for the addictions field
10.1111/j.1360-0443.2010.03218.x · 2011 · External reference
Impulse control disorder in parkinson’s disease: A meta-analysis of cognitive, affective, and motivational correlates
10.3389/fneur.2018.00654 · 2018 · External reference
Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease
10.1136/jnnp-2015-311827 · 2016 · External reference
A multicenter comparative study of impulse control disorder in latin american patients with parkinson disease
10.1097/wnf.0000000000000202 · 2017 · External reference
Management of impulse control and related disorders in parkinson’s disease: an expert consensus
10.1002/mds.29700 · 2024 · External reference
Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients
10.1001/archneurol.2010.65 · 2010 · External reference
Impulsivity and compulsivity in drug‐naïve patients with Parkinson’s disease
10.1002/mds.23501 · 2011 · External reference
Impulse control disorders in Parkinson’s disease: don’t set your mind at rest by self‐assessments
10.1111/ene.12646 · 2015 · External reference
Metacognition, executive control, self-regulation, and other more mysterious mechanisms
1987 · External reference
How to measure metacognition
10.3389/fnhum.2014.00443 · 2014 · External reference
Unresolved reference
2009 · External reference
A short form of the metacognitions questionnaire: Properties of the MCQ-30
10.1016/s0005-7967(03)00147-5 · 2004 · External reference
Modelling cognition in emotional disorder: The S-REF model
10.1016/s0005-7967(96)00050-2 · 1996 · External reference
Breaking the cybernetic code: Understanding and treating the human metacognitive control system to enhance mental health
10.3389/fpsyg.2019.02621 · 2019 · External reference
Dysfunctional metacognition across psychopathologies: A meta-analytic review
10.1016/j.eurpsy.2017.05.029 · 2017 · External reference
Metacognition in addictive behaviors
10.1016/j.addbeh.2014.08.002 · 2015 · External reference
Metacognitive beliefs in addictive behaviours: A systematic review
10.1016/j.addbeh.2018.05.018 · 2018 · External reference
Movement disorder society unified parkinson’s disease rating scale motor examination retains its 2‐Domain profile in both on and off states
10.1002/mdc3.13566 · 2022 · External reference
Parkinsonism: onset, progression, and mortality
10.1212/wnl.17.5.427 · 1967 · External reference
Montreal cognitive assessment (MoCA)
2005 · External reference
Italian validation of montreal cognitive assessment
10.1027/1015-5759/a000217 · 2015 · External reference
The Frontal Assessment Battery (FAB): normative values in an Italian population sample
10.1007/s10072-005-0443-4 · 2005 · External reference
DSM-5 cross-cutting symptom measures: a step towards the future of psychiatric care
10.1002/wps.20154 · 2014 · External reference
Systematic review of levodopa dose equivalency reporting in Parkinson’s disease
10.1002/mds.23429 · 2010 · External reference
Levodopa dose equivalency in parkinson’s disease: updated systematic review and proposals
10.1002/mds.29410 · 2023 · External reference
Questionnaire for impulsive‐compulsive disorders in Parkinson’s Disease–Rating Scale
10.1002/mds.24023 · 2012 · External reference
Validation of the Italian version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS) in an Italian Parkinson’s disease cohort
10.1007/s10072-024-07304-2 · 2024 · External reference
Psychometric properties of the Italian version of the Short Form of the Metacognitions Questionnaire (MCQ-30)
2014 · External reference
Metacognitions questionnaire–short form (Italian version, MCQ-30)
2014 · External reference
Unresolved reference
External reference
Controlling the false discovery rate: A practical and powerful approach to multiple testing
10.1111/j.2517-6161.1995.tb02031.x · 1995 · External reference
Benjamini–hochberg method
10.1007/978-1-4419-9863-7_1215 · 2013 · External reference
The montreal cognitive assessment, moCA: A brief screening tool for mild cognitive impairment
10.1111/j.1532-5415.2005.53221.x · 2005 · External reference
Longitudinal analysis of impulse control disorders in Parkinson disease
10.1212/wnl.0000000000005816 · 2018 · External reference
Distress in Parkinson's disease: contributions of disease factors and metacognitive style
10.1192/bjp.187.2.182 · 2005 · External reference
Thinking about motor fluctuations: An examination of metacognitions in Parkinson's disease
10.1016/j.jpsychores.2015.05.001 · 2015 · External reference
The clinical utility of metacognitive beliefs and processes in emotional distress in people with multiple sclerosis
10.1016/j.jpsychores.2017.11.014 · 2018 · External reference
Metacognitive beliefs and illness perceptions are associated with emotional distress in people with epilepsy
10.1016/j.yebeh.2018.07.008 · 2018 · External reference
The association between maladaptive metacognitive beliefs and emotional distress in people living with amyotrophic lateral sclerosis
10.3389/fpsyg.2021.609068 · 2021 · External reference
Association between metacognition and mood symptoms poststroke
10.1177/0891988716640374 · 2016 · External reference
Metacognitive beliefs, mood symptoms, and fatigue four years after stroke: An explorative study
10.1371/journal.pone.0305896 · 2024 · External reference
Metacognitive beliefs and addictions: A systematic review and meta-analysis with emphasis on the mediating role of desire thinking
10.1016/j.addbeh.2026.108613 · 2026 · External reference
A brief history of metacognitive therapy: From cognitive science to clinical practice
10.1016/j.cbpra.2021.11.002 · 2023 · External reference
Impulse control disorders in Parkinson's disease. A brief and comprehensive review
10.3389/fneur.2019.00351 · 2019 · External reference
Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [11C]-PHNO PET study
10.1016/j.parkreldis.2021.06.025 · 2021 · External reference
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study
10.1093/brain/awp054 · 2009 · External reference
Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours
10.1093/brain/awr003 · 2011 · External reference
Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease
10.1212/wnl.0000000000001619 · 2015 · External reference
Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease
10.1002/mds.27139 · 2017 · External reference
Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder
10.1093/brain/awaa198 · 2020 · External reference
Impulse control disorder in Parkinson's disease is associated with abnormal frontal value signalling
10.1093/brain/awad162 · 2023 · External reference
